All companies
Visit website
OsNovum
OperatingOsNovum, Inc.
Founded 2020
We improve skeletal health to extend lifespan and increase quality of life
Post-money valuation ⓘ
$19.5M
As of Apr 2025 · from OSNOVUM Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$204,350
Across 2 rounds since 2020
Latest share price
$40.00
OSNOVUM Preferred Stock 2 offering price
Financials
FY2018–FY2023 · from SEC filings · hover any figure for its source$0
2018
$0
2019
$5
−$84K
2022
$5
−$23K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2022
FY2023
Income statement
Revenue
$0
$0
$5
$5
Cost of goods sold
$0
$0
$0
$0
Gross margin
—
—
100%
100%
Net income
$0
$0
-$84,187
-$22,650
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$100
$18,144
$137
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$0
$18,144
$137
Short-term debt
$0
$0
$0
$4,643
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$0
$0
$4,643
Other
Headcount
—
4
—
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$14.6M
post-money
$19.5M
post-money
OsNovum Stock 1
OSNOVUM Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised — / $200KPost-money $19.5M
Raised $204.4K / $1.1MInvestors 146Post-money $14.6M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 6 annual reports (FY2020–FY2025)
146 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001825224Share price $40.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.